Undeterred Capital

Undeterred Capital Research Investment Thesis Undeterred Capital is an early-stage venture firm focused on scientific and technological breakthroughs in biological platforms and applied robotics. Founded in 2020 by Joe Wilson, the firm partners with founders commercializing deep tech innovations, helping them solve operational and commercialization challenges beyond just technical risk. The firm's north star: "The breakthrough is the beginning." They believe the biggest challenges deep tech businesses face aren't technical — they're operational: navigating regulatory minefields, choosing markets, forging customer connections. Sector Focus Undeterred invests exclusively in two areas: Biological Platforms: Synthetic biology Material science AI for drug discovery Cell engineering Food supply chain / biomanufacturing Applied Robotics: Autonomy systems Chemical automation Swarm robotics Infrastructure for hardware design Deep space / aerospace applications They explicitly avoid software-only plays — the firm is deep tech focused. Stage Focus Inception / Pre-Seed — 80%+ of investments at pre-seed or earlier Seed — Follow-on and selective new investments They invest "from incorporation to seed stage" Check Size Initial checks: $500K - $1M Lead tendency: Frequently leads or co-leads rounds Lead Tendency Leads or co-leads frequently. They position themselves as lead investors who provide operational support, not just capital. Portfolio Highlights Applied Robotics: AstroForge — Deep space asteroid mining (inception stage) Newlight — Decarbonizing shipping via hydrogen integration Zoo — Infrastructure for hardware design Shinkei — Robotic fish processing (acquired) Biological Platforms: Parallel Bio — AI-powered organoid screening for immunotherapies (acquired) Curative — Sustainable healthcare platform (acquired) Index Biosystems — Synthetic biology for food supply chain risk Portal — Next-gen cell engineering Several portfolio companies have already been acquired, indicating strong exit velocity for a firm founded in 2020. Team Joe Wilson — Founder & Managing Partner Founded Undeterred Capital in 2020 Previously: Co-founder & COO of Multiply Labs (MIT spinout, YC/Lux/Casdin backed) Former venture partner at MarsBio Co-founder of C19 Coalition (1B+ PPE items delivered) Lectures on deep tech commercialization at MIT, Duke, Caltech, USC, UCLA Based in Los Angeles Emily Lindberg — Associate & Head of Research PhD in Biomechanics from UC Berkeley Specializations in cell biology and material science Former Fellow at MPM Bioimpact (Boston) Kylie Trettner — Investment & Research Analyst PhD in Chemical Engineering from USC Nucleate LA Activator finalist (2023) Interdisciplinary biophysics background Paul Scott — CFO (part-time) 20+ years as CFO at biotech VC firms CFO at BioStar Ventures ($200M firm) since 2006 Former CEO/Chairman at VSI Enterprises (NASDAQ) Decision Process Small partnership led by Joe Wilson. Deep technical diligence given team's PhD-level expertise across biomechanics, chemical engineering, and synthetic biology. They emphasize operational support alongside capital. Geographic Focus Primary: Los Angeles / Southern California Secondary: Deep tech hubs (Boston, SF Bay Area, etc.) US-focused but sector-driven rather than geo-driven Founder Preferences Technical founders with scientific breakthroughs Teams facing operational/commercialization challenges, not just technical risk Founders building "durable, generational companies" in deep tech Domain experts in biology, robotics, or materials science Differentiators Deep tech operational expertise — Team has built and scaled deep tech companies, not just invested Sector specialization — Only two focus areas (bio platforms, applied robotics) Inception-stage focus — 80%+ at pre-seed or earlier Lead investor positioning — Frequently leads or co-leads Strong exit velocity — Multiple acquisitions already despite firm being founded in 2020